Wave 4
Service Specifications
- Specialised Respiratory Services (adult) – Severe Asthma
- Specialised Vascular Services (Adults)
Clinical Commissioning Policies
- Pegvisomant for acromegaly as a third-line treatment (adults)
- Tolvaptan for hyponatraemia secondary to the Syndrome of Inappropriate Antidiuretic Hormone (SIADH) in patients requiring cancer chemotherapy
- Cinacalcet for complex primary hyperparathyroidism
- Teriparatide for the treatment of osteogenesis imperfecta (Adults)
- Pasireotide for acromegaly as third-line treatment (adults)
- Rituximab for immunoglobulin G4-related disease (IgG4-RD)
- Immune Tolerance Induction (ITI) for haemophilia A (all ages)
Wave 5
Clinical Commissioning Policies
- Urethroplasty for benign urethral strictures in adult men
- Surgical sperm retrieval for male infertility
- Penile prosthesis surgery for end stage erectile dysfunction
- Fampridine for multiple sclerosis (adults)
- Ziconotide (intrathecal delivery) for chronic refractory cancer pain
- Autologous chondrocyte implantation for osteochondral lesions of the talus (adults)
- Bone morphogenetic protein-2 in spinal fusion
- Everolimus for subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex